Testing Services Overview
National Genetics Institute (NGI) provides advanced clinical genetics testing services for blood screening, medical testing, and clinical research. The company offers industry leading assays for human immunodeficiency virus (HIV), hepatitis A, B, and C (HAV, HBV, and HCV) viruses, Parvovirus B19, and other infectious agents and has pioneered robust, sensitive, and high throughput methods for pooled specimen nucleic acid testing.
NGI is a leading provider of nucleic acid screening services to the global biotechnology industry and screens millions of plasma donations a year for blood borne infectious agents (Screening Services). The company also provides its advanced genetic testing services to physicians, hospitals, and clinics (Medical Testing) and has supported numerous pharmaceutical and biotechnology companies in the clinical development of new infectious disease and oncology therapies (Clinical Research Services).
NGI is licensed as a clinical laboratory provider by both state and federal agencies, participates in a number of approved quality control programs, and holds active Biologics Licenses from the US Food and Drug Administration (FDA) for screening of Source Plasma donors for HCV, HIV-1, and HBV.